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Abstract 
A biochemical characterization f a Mg2+-ATPase activity associated with a plasma membrane fraction isolated from airway 
(tracheal) smooth muscle was performed. This enzyme is an integral part of the membrane remaining tightly bound after 0.6 M KC1 
extraction. This enzyme activity showed a cold inactivation i the presence of ATP and Mg 2+. Also, this Mg2÷-ATPase was stimulated 
by monovalent anions being CI-, the best anion for such stimulation, even though Br-  and I -  were good substitutes and F -  was 
ineffective. This C1--stimulated activity showed a powerful nucleosidetriphosphatase activity having the following divalent cation 
specificity: Mg2+>Mn2+>Ca 2+, where Zn 2+ and Fe 2+ were ineffective. This ATPase activity was not inhibited by ouabain, 
oligomycin C and vanadate indicating that neither P- or F-ATPases were associated with this enzyme activity. However, the existence of 
a V-ATPase was shown by the significant inhibition causes by bafilomycin A L. Additionally, this V-ATPase seems to be coupled to CI 
conductor because duramycin inhibited this ATPase activity. The presence of a H + pump associated to this V-ATPase was shown 
indirectly, through the stimulatory effect produced by uncouplers uch as FCCP and 1799, which were able to produce significant 
stimulation of this V-ATPase indicating the existence of a H+-ATPase. Finally, the immunodetection f a 72 kDa polypeptide using a 
specific antibody against the A subunit (72 kDa) of V-ATPase from chromaffin granule demonstrated the presence of a V-ATPase in this 
plasma membrane fraction. 
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1. Introduction 
It is well established that mammalian cells have pH i 
levels near or slightly above neutrality and the mainte- 
nance of the cytoplasmic pH (pH i) in the physiological 
range is essential for cell function and survival [1]. Mam- 
malian cells have transmembrane potentials in excess of 50 
Abbreviations: DCCD, N,N'-dicyclohexylcarbodiimide; DTT, dithio- 
threitol; EDTA, ethylenediaminetetraacetic acid; FCCP, carbonylcyanide 
p-trifluoromethoxyphenylhydrazone; GMP-PNP, 5'-guanylimi- 
dodiphosphate; H+-ATPase, H+-translocating ATPase (H + pump); QNB, 
quinuclidinyl benzylate; Mes, 2-(N-morpholino)ethanesulfonic acid; 
NaN 3, sodium azide; NEM, N-ethylmaleimide; p-CMB, p-chloro- 
mercuribenzoate; PMSF, phenylmethylsulfonyl fluoride; V-ATPase, vac- 
uolar adenosine triphosphatase; 1799, bis(hexafluoroacetonyl)acetone. 
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mV (negative inside), which is a driving force for H ÷ to 
accumulate lectrophoretically inside the cell. Moreover, 
after metabolic ell activation, a dramatic increment in H ÷ 
production occurs in contractile cells like smooth muscle 
as a consequence of ATP hydrolysis [2]. These findings 
imply that in order to maintain pH i within the physio- 
logical range, active process have to evolve to extrude 
excess H ÷ (equivalents) from the cytoplasm to the extra- 
cellular medium. One of the primary mechanisms involved 
in the extrusion of H ÷ from mammalian cells is a H ÷ 
pump associated with plasma membranes [3,4]. The bio- 
chemical expression of this H ÷ pump is a membrane 
bound Mg2+-ATPase activity generally associated to a 
vacuolar (V-ATPase) [5-7]. The V-ATPases are found in 
fungi and plant vacuoles [8,9] and also in eukaryotic 
intracellular membrane compartments such as lysosomes 
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[10,11], clathrin-coated vesicles [12], Golgi vesicles [13], 
endocytic vesicles [14,15], and synaptic vesicles [16]. 
However; a vacuolar H+-ATPase is found in the plasma 
membrane of renal intercalated cells, where it is thought o 
be involved in the process of urinary acidification [4]. 
However, these proton pumps are thought to originate 
from intracellular membrane vesicles which, under stimu- 
lation, are fused with the plasma membrane. A similar 
mechanism has been suggested for osteoclast acidification 
[17]. In this present study, we described a biochemical 
characterization f an anion-stimulated Mg2+-ATPase (V- 
ATPase). Moreover, this V-ATPase activity is linked to a 
H + pump and a CI- conductor at plasma membrane 
vesicles isolated from tracheal smooth muscle. Parts of this 
work have previously been published in abstract form [ 18]. 
2. Materials and methods 
wet weight tissue, in a Waring blender at full speed for 30 
s with 1 min interval on ice. The dispersed material was 
centrifuged at 850 X g for 10 rain and the supernatant 
(E-I) was saved. The sediment was re-extracted with 2 vol. 
of buffer IS/g wet tissue and processed as described 
above. The supernatant (E-II) was saved and the sediment 
was again extracted with 2 vol. of Buffer IS/g wet tissue 
and filtered sequentially through 2, 4, 8 layers of cheese- 
cloth. The filtrate was centrifuged at 1000 X g for 10 min 
to separate the Nuclear fraction (N) and the supernatant 
(E-Ill) was pooled with E-I and E-II. The combined extract 
is referred to as Fraction E. It was centrifuged at 31 000 x g 
for 15 min to sediment a mitochondriai fraction (Fraction 
M) and the postmitochondrial supernatant was centrifuged 
at 150000 X g for 1 h yielding a microsomal fraction 
(Fraction P) and the soluble fraction (S) or cytosol. All 
particulate fractions were suspended in small volume of 
Buffer IS. 
Reagents were purchased from the following sources: 
ATP(A-5394) or Tris-ATP, other tri-, di- and monophos- 
phate nucleosides, valinomycin, sodium vanadate, sucrose, 
PMSF, DTT, p-CMB, ouabain, creatine phosphokinase 
(rabbit muscle, type I), creatine phosphate, GMP-19NP, 
5'-AMP, Trizma, Mes and peroxidase conjugated goat- 
anti-rabbit immunoglobulin G were from Sigma. The 
reagents for the Pi determination a d EDTA from Merck. 
The 1799 and FCCP protonophores, duramycin and ru- 
tamycin (oligomycin C) were kindly provided by E. Racker 
(Cornell University, Biotechnology Center, USA). RO- 
201724 was purchased to RBI (USA). The kits for the 
quantification of cAMP and [3H]QNB (35.5 Ci/mmol) 
were purchased from the Radiochemical Centre, Amer- 
sham (UK). Other reagents were the highest purity avail- 
able and the electrophoresis and immunoblotting reagents 
were purchased from Bio-Rad. An antibody against A 
subunit of V-ATPase and bafilomycin A~ were kindly 
provided by N. Nelson from Roche Institute (Nutley, New 
Jersey, USA). 
2. I. Preparation of  subcellular fractions from tracheal 
smooth muscle 
The fractionation of bovine tracheal smooth muscle was 
performed as described previously [ 19] and briefly summa- 
rized: Bovine trachea and bronchii from 10 cows were 
transported on ice from the slaughterhouse to the labora- 
tory. The thin layer of smooth muscle holding the cartilage 
was dissected on ice after the removal of serosa, mucosa 
and submucosa l yers. All subsequent manipulations were 
performed at 4°C. The smooth muscle (about 250 g) was 
rinsed with 20 mM Tris-HC1 (pH 7.2) containing 0.3 M 
sucrose, 0.5 mM DTT and 0.25 mM PMSF (Buffer IS), 
minced and homogenized twice with 3 vol. of Buffer IS/g 
2.2. Isolation of plasma membrane fractions 
Fraction P was dispersed into 75 ml of Buffer IS. 15-ml 
samples were fractionated on a discontinuous sucrose gra- 
dient (0.3 M/0.82 M/1.28 M) in a SW 28 type Beckman 
rotor at 80000 X g for 1 h. Three fractions, Pl(in the 
interphase between 0.3 M and 0.82 M), P2 (in the inter- 
phase 0.82 M/1.28 M) and P3 (at the bottom) were thus 
obtained. PI and P2 (combined from six tubes) were each 
diluted separately with 80 ml of 20 mM Tris-HC1 (pH 7.2), 
0.5 mM DTT, 0.25 mM PMSF (Buffer I) and centrifuged 
at 150000 X g for 30 min. Fractions PI, P2 and 193 were 
suspended in 10 ml of Buffer IS divided into small aliquots, 
frozen in liquid nitrogen and stored at -80°C. 
2.3. Enzyme determination 
ATPase activity. In order to measure the membrane 
bound ATPase, all subcellular fractions were extracted 
with 0.6 M KC1 at 4°C as follows: Approximately, 2 mg of 
protein was extracted under gentle agitation with 20 ml of 
a medium containing 0.3 M sucrose, 0.5 mM DTT, 0.6 M 
KC1, 20 mM Tris-HC1 (pH 7.2) by I h and later cen- 
trifuged at 150 000 X g for 30 min. Sediments were washed 
twice with a buffer containing 0.3 M sucrose, 0.5 mM 
DTT, 20 mM Tris-Mes (pH 7.0) to remove traces of KCI 
and suspended in small volume of the last buffer. The 
standard assay of the membrane bound ATPase was 980 
Ixl of buffer consisting of 30 mM Tris-Mes (pH 6.9), 5 
mM MgC12, 5 mM ATP in the presence or absence of 0.15 
M KC1, preincubated at 37°C for 5 min and the reaction 
was started by the addition of 20 ixl (20-50 txg protein) 
and incubated for 1 rain. Unless otherwise specified, all 
assays were performed at 37°C. Reactions were terminated 
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by addition of 0.1 ml of 50% cold TCA, followed by 
centrifugation at 3000 × g for 10 min. The enzyme activ- 
ity (ATPase) was quantified by measuring the amount of Pi 
released using the procedure of Fiske-SubbaRow modified 
by Grant and us as previously described [20]. Protein 
determination was performed using bovine serum albumin 
as standard following a procedure described by Bensadoun 
and Weinstein [21]. 
Adenylyl cyclase activity (EC 4.6.1.1). This enzyme 
was assayed [22] in a total volume of 100 p,1 containing 50 
mM Tris-HC1 (pH 7.6); 5 mM MgC12; 3.2 mM ATP; an 
ATP regenerating system (5 mM creatine phosphate and 
10 IU phosphocreatine kinase per assay in 0.1% defatted 
bovine serum albumin); 1 mM DTT; 20 IxM RO20-1724; 
0.1 mM GMP-PNP, and 10-50 I~g of protein were added. 
The sediments of the particulate fractions were resus- 
pended and later diluted with a 50 mM phosphate buffer 
(pH 7.4) and 4 mM MgC12. The incubation was carried 
out at 37°C for 5 min and determined by addition of l0 p,1 
of 167 mM EDTA-Tris (pH 7.5), followed by heating for 3 
rain in a boiling water bath, and cooling on ice. The cAMP 
was determined by radioanalysis (Amersham, Kit No. 
TRK432) in 25 p~l supernatant of the reaction mixture 
obtained after centrifugation at 12000 X g for 10 min at 
4°C. 
5'-Nucleotidase activity (EC 3.1.3.5). This activity was 
estimated in an incubation media (0.5 ml) containing 50 
mM Tris-HCl; pH 7.5 buffer; 10 mM MgC12; 5 mM 
5'-AMP. Incubations were initiated by addition of the 
enzyme sample (50-500 p~g of protein) and the reaction 
was continued for 5 min at 37°C. Reactions were termi- 
nated by addition of 1 ml of 10% cold TCA, followed by 
centrifugation at 1000 × g for 10 min. Pi was determined 
in the supernatant by the method of Bartlett [23]. 
[3H]QNB-binding activity. Muscarinic receptor was de- 
termined by using the [3H]QNB-binding activity was per- 
formed according the procedure described by Lippo de 
Brcemberg et al. [24] with 2-5 Ixg protein per assay at 
1200 pM of [3H]QNB. 
Gel electrophoresis and immunoblotting procedure for 
detection of A-subunit of V-ATPase. Plasma membrane 
fraction (P1) having the V-ATPase activity was dissolved 
and reduced with 2% SDS and 2% of 2-mercaptoethanol, 
electrophoresed through 10% polyacrylamide g ls accord- 
ing to the procedure described by Laemmli [25]. Protein 
bands were transferred onto nitrocellulose membranes. Po- 
tential non-specific binding sites on the transferred mem- 
branes were blocked for 1 h with 5% (wt/vol) dry milk 
and 0.05% (vol/vol) Tween 20 dissolved in PBS solution 
(PBS-T). The latter solution was removed and membranes 
were washed with PBS-T buffer and incubated for 1 h with 
a polyclonal antibody against A subunit of chromaffin 
granule V-ATPase previously diluted in PBS-T with 5% 
dry milk. After being washed, the membranes were incu- 
bated for 1 h with peroxidase conjugated goat-anti-rabbit 
immunoglobulin G, previously diluted in PBS-T with 5% 
dry milk. Bound antibody was visualized by an enhanced 
chemiluminescense detection system (E.C.L. Western blot- 
ting detection Kit from Amersham) and exposed to Kodak- 
X-Omat film. The polypeptide molecular weight standards 
(Sigma) were detected by staining with Coomassie brilliant 
blue. 
Table 1 
Subcellular distribution of V-ATPase, 5'-nucleotidase, GMP-PNP-stimulated adenylyl cyclase and L-[3 H]QNB binding as muscarinic receptor activity from 
bovine tracheal smooth muscle 
Fractions V-ATPase 5'-Nucleotidase GMP-PNP-adenylyl cyclase L-[3H]QNB binding 
S.A. (*) S.A. (*) S.A. (*) S.A. (*)  
E 0.26 + 0.02 1.0 65 + 6 1.0 70 ___ 5 1.0 200 + 17 1.0 
N 0.15 +0.06 0.6 35 + 5 0.5 155 + 12 2.2 181 _+ 34 0.9 
M 1.13 + 0.15 4.3 98 + 7 1.5 295 _+ 35 4.2 596 + 33 2.9 
P 0.14 + 0.03 0.5 128 + 9 1.9 215 _+ 20 3.1 886 + 47 4.4 
S 0.07 + 0.02 0.2 44 ___ 3 0.7 n.d. 28 + 7 
P~ 4.00 + 0.20 15.3 360 + 8 5.5 400 + 40 5.7 1468 _+ 138 7.3 
P2 1.14 + 0.05 4.4 134 + 9 2.0 338 + 40 4.8 1378 _+ 169 6.9 
P3 0.18+0.03 0.7 99+7 1.4 41 + 10 0.6 217+ 49 1.1 
All determinations were performed in the sediments of the fractions with the exception of fractions S. V-ATPase was calculated as the difference of the 
Mg2+-ATPase activities in the presence of 0.15 M KCI minus the activity in absence of KC1. These ATPases were measured as described in Section 2. 
V-ATPase is expressed as i~mol Pi/min per mg protein. 5'-Nucleotidase is expressed as i~mol Pi/min per mg protein. GMP-PNP-stimulated adenylyl 
cyclase as pmol cAMP/min per mg protein resulting from subtracting the basal specific activity from the specific activity in the presence of 0.1 mM 
GMP-PNP. L-[3H]QNB binding (muscarinic receptor) activity as fmol L-[3H]QNB/mg protein; was measured in the presence of 1200 pM L-[3H]QNB. 
Data are means + S.E. of duplicate determinations from 5-7 separate subcelullar f actionations, n.d., not detected; E, total extract; N, nuclear fraction; M, 
mitochondrial fraction; P, microsomal fraction; Pi, light plasma membrane fraction; P2, heavy plasma membrane fraction and P3, sarco(endo)plasmic 
reticulum fraction. S.A., specific activity and (" ), purification was calculated as the ratio of specific activity of each fraction/specific activity of fraction 
E. 
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3.  Resu l ts  
3.1. Location of V-ATPase on subcellular fractionation of 
tracheal smooth muscle 
Initial experiments were performed to estimate the ac- 
tivity of Mg2+-ATPase in the different subcellular frac- 
tions isolated from airway smooth muscle according with a 
procedure described in Section 2. These results are shown 
in Table 1. It can be observed that fraction P~, which is an 
enriched in plasma membrane vesicles fraction showed the 
highest specific activity for the chloride-stimulated AT- 
Pase (V-ATPase) and other plasma membrane markers 
such as 5'-nucleotidase, GMP-PNP-adenylyl cyclase and 
muscarinic receptor were highly enriched in this PI frac- 
tion, which supports the origin of this PI plasma mem- 
brane fraction. 
3.2. Characterization of the V-ATPase activity 
The high ATPase activity remains tightly bound to the 
plasma membrane fraction (P~), after a high-salt extraction 
procedure (0.6 M KCI). This ATPase activity was found to 
be linear with respect o time for at least 2 min. Moreover, 
this enzyme activity was linear between 5 to 50 bg of 
membrane protein (data not shown). 
Cold inactivation in the presence of ATP and Mg 2÷ is 
an important property exhibited by V-ATPases. In order to 
evaluate this specific property, a similar classic cold inacti- 
vation experiment was performed and the results are shown 
in Fig. l. Under these experimental conditions, 50% of the 
ATPase activity was lost in 5 min at 4°C while the ATPase 
at 25°C remained for longer times. 
3.3. Effects of specific inhibitors for P-, F- or V-ATPases 
The effects of specific inhibitors for P-, F- and V- 
ATPases on this chloride-stimulated Mg2+-ATPase are 
summarized in Table 2. Ouabain, a classical inhibitor of 
the Na+,K+-ATPases produces a 30% inhibition of the 
basal activity at 1 mM whereas the C1--stimulated activity 
was not significantly affected for this inhibitor. Sodium 
vanadate, an specific inhibitor of P-ATPases produced a 
similar percentage inhibition of the basal activity found for 
ouabain; suggesting that at least 30% of the basal activity 
may be P-ATPases associated to this plasma membranes. 
In these experiments, cross contamination with inner mito- 
chondrial membranes was ruled out because these latter 
membranes also contain a Mg2+-ATPase (F0-FI-ATPase), 
which is well known to be sensitive to oligomycins or 
NaN 3. Both the basal activity and the C1--stimulated 
activity are not affected in the presence of 0 .5-5 I~g/ml of 
ol igomycin C (rutamycin) and 1-5 mM NaN 3 (data not 
shown). This evidence indicates the absence of mitochon- 
drial contaminants in this plasma membrane fraction. 
However, bafi lomycin A1 at low concentration ( M range) 
120- 
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Fig. 1. Cold inactivation of chloride-activated Mg2+-ATPase. Plasma 
membranes (0.4-0.6 mg/ml) were incubated in the presence of 5 mM 
ATP, 0.2 M NaCI, 5 mM MgCI 2, 0.5 mM DTT, 20 mM Tris-Mes (pH 
6.8) containing 5 mM creatine phosphate and 20 I~g creatine kinase at 
room temperature ( I )  or at 0°C (D). Aliquots (20 ~1) were taken at 
indicated time and the ATPases activities were measured as described in
Section 2. The 100% activity was 7.89+0.7 p~mol Pi/min per mg 
protein. 
Table 2 
Effect of several inhibitors on Mg2+-ATPase 
Inhibitor I~mol Pi/min per mg protein 
+ KC1 - KCI A 
None 7,80+0.16 4.86+0.15 2.94 
Ouabain 1 mM 6,84+0.16 4.44+0.18 2.40 
10 mM 6.84+0.20 4.45 +0.13 2.40 
Vanadate 50 ~M 7.73+0.13 3.81 +0.10 3.92 
500 p~M 7.71 +__0.11 2.76+0.10 4.74 
Oligomycin C 0.5 p,g/ml 7.80+0.15 4.76+0.12 3.04 
5 i~g/ml 6.59+0.14 3.08+0.23 3.51 
Bafilomycin A1 100 nM 5.43 +0.12 4.85 +0.12 0.58 
The Mg2+-ATPase activity was measured in Pi fraction (20-50 Ixg 
protein) as described inSection 2. Oligomycin C was dissolved in ethanol 
and control experiments u ing 2 I~1 of ethanol for 1 ml of assay mixture 
were done. Bafilomycin A j was dissolved in DMSO and the final 
concentration f DMSO was always less than 1%. A, V-ATPase activity 
calculated by substracting from the Mg 2 +-ATPase in the presence of0.15 
M KCI the basal activity, Data represent the means+S.E of three 
separate experiments performed in triplicate. 
was able to inhibit in more than 80% of the C1--stimulated 
ATPase demonstrating the presence of a V-ATPase in this 
plasma membrane fraction as shown in Table 2. 
3.4. pH dependency 
The pH dependency of this V-ATPase was evaluated. 
Thus, this enzyme activity was assayed over a wide range 
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Fig. 2. The pH profile of the chloride-stimulated Mg2+-ATPase. The 
different pH solutions were prepared using Tris-Mes buffers. The ATPase 
activity was measured as described in Section 2. r-1 -KCI ;  B,  +KCI 
0.15 M. zx, chloride-stimulated ATPase was calculated by subtracting 
from the KCl-stimulated activity the basal activity. Each value is the 
mean of three experiments done in triplicate. 
of pH from 5.0 to 9.0 using Tris-Mes mixtures as free 
chloride buffers. The chloride stimulation was observed to 
remain the same from pH 5.0 to 6.5, it showed an optimum 
at pH 6.9-7.0, it decreased sharply and it was virtually 
absent at pH values higher than 7.2 (Fig. 2). Nevertheless, 
the basal activity did not show a sharp pH dependency. 
3.5. Anion specificity 
The addition of KCI seems to be a requirement for the 
stimulation (twice) of the basal ATPase activity. Thus, the 
anion specificity was explored using different chloride 
salts as KC1, KNO 3, K + gluconate and K2SO 4 as shown 
in Fig. 3. From these data, KCI was the best K ÷ salt for 
activating this ATPase followed by KNO 3, which stimu- 
lated the activity by 20% at low concentration (10-50 
mM) and this stimulation disappeared at concentrations 
higher than 100 mM. On the other hand, K2SO 4 produced 
only 10% stimulation (10-25 mM) and was ineffective at 
concentrations higher than 50 mM. However, K + glu- 
conate (10-300 mM) was totally ineffective. 
3.6. Effect of monovalent cations 
The cation specificity of this enzyme was done using 
KCI, NaC1, RbC1 and Tris-HCl at 0.15 M and all these 
salts produced stimulation of the Mg2+-ATPase as shown 
in Table 3A. Thus, the following sequence of activation 
was found for monovalent cations: K ÷ > Na ÷ > Tris >__ Rb ÷ 
suggesting that K + is more effective than Na ÷ and Rb ÷. It 
is important o point out that there was not additional 
80 
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o 
c 
g 40  
el 
[ 
I I  
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0 . . . .  , ~  
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Fig. 3. The effect of different K + salts on the MgZ+-ATPase activity. 
The ATPase was measured following the procedure described in Section 
2. The enzyme activity is expressed as the percentage of activation of 
basal activity of each group of experiments. Basal activity (100%) = 4.0 
5-0.8 Ixmol P~/min per mg protein. It, KCI; 13, KNO3; zx, K glu- 
conate; * ,  K2SO 4. Each value is the mean of three experiments done in 
triplicate. 
Table 3 
Dependence on different chloride salts (A) and halogen salts (B) of the 
activity of Mg 2 +-ATPase 
p~mol P i /min per mg protein 
activity A 
(A) Chloride salt 
None (basal) 4.78 + 0.20 0 
KCI 8.94_+0.19 4.16 
NaC1 7.92 5- 0.21 3.14 
Tris-HC1 7.20 5- 0.13 2.42 
RbC1 6.40 5- 0.16 1.62 
(B) Halogen salt 
None (basal) 4.78 + 0.16 0 
KCI 10.20-t-0.15 5.42 
KI 10.165-0.08 5.38 
KBr 10.09+0.11 5.31 
KF 5.46 5- 0.14 0.68 
NaCI 9.92 + 0.12 5.14 
NaI 9.11 5-0.14 4.33 
NaBr 9.92 5- 0.09 5.14 
NaF 5.46 5- 0.15 0.68 
(A) This Mg2+-ATPase activity was measured as described in Section 2. 
The final concentration of chloride salts was 0.15 M, using 5 mM ATP 
and 5 mM Mg 2+ acetate. In the case of Tris-HC1, a solution of 
Trizma-HCl was adjusted with 2 M Tris to pH 6.9. 
(B) The experimental conditions were similar to those described in (A). 
All different K ÷ or Na ÷ salts were prepared to obtain a final concentra- 
tion of 0.15 M. A, the difference in activity after subtracting the activity 
under basal conditions from the activity under each experimental condi- 
tion. Data represent the means + S.E. of four separate xperiments done in 
triplicate. 
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Table 4 
The effect of different nucleotides (A) and divalent cations (B) on 
Mg 2 + -ATPase 
Activity (Ixmol Pi/min per mg protein) 
+ KC1 - KCI A 
(A) Nucleotides 
None 0 0 0 
ATP 9.65 +__ 0.20 5.70 + 0.26 3.95 
CTP 10.20+0.29 7.81 +0.25 2.39 
UTP 8.98+0.28 4.39+0.17 4.59 
GTP 7.50+0.29 4.56+0.10 2.94 
ADP, CDP, UDP, GDP 0 0 0 
AMP, CMP, UMP, GMP 0 0 0 
(B) Ion condition 
Without addition 1.04 + 0.07 0.74 + 0.04 0.30 
MgC12 8.86+0.13 4.47+0.18 4.39 
MnCI 2 7.88+0.09 4.41 +0.14 3.47 
CaC12 6.03 + 0.04 5.02 + 0.09 1.01 
ZnCI 2 1.39+0.10 1.22+0.03 0.17 
FeC12 1.10+0.05 0.72+0.05 0.38 
(A) The Mg2+-ATPase activity was measured asdescribed in Section 2. 
All nucleotide solutions were neutralized to pH 6.9 with Tris. Blank 
experiments without membranes were run to evaluate the hydrolysis of 
these nucleotides, which was negligible. The final concentration f the 
nucleotide was 5 mM and 5 mM MgC12 was employed in all assays. 
(B) The enzyme activity was measured as described in Section 2. The 
amount of ATP was 5 mM and the final concentration f the divalent 
cation was 5 mM. A, the enzyme activity obtained by subtracting the 
ATPase activity in the absence ofKCI from the activity in the presence of
KC1. Data represent the means +__ S.E. of three separate experiments done 
in triplicate. 
activation by chloride salts as 300 mM NaC1 added on top 
of 150 mM KC1 did not provide additional stimulation 
(data not shown). 
3.7. Halogen selectir'ity 
dinucleotides were hydrolyzed. However, it was found that 
all nucleotide triphosphates were good substrates for these 
enzyme activities. Thus, the basal activity was higher in 
the presence of CTP and ATP and a lower activity with 
UTP and GTP. One unusual finding was the high UTPase 
activity and additional experiments in the presence of 
bafilomycin were performed. It was found that only 20% 
of the chloride-activated UTPase was sensitive to this 
inhibitor (data not shown), in contrast with the 80% inhibi- 
tion for the ATPase activity showed in Table 2. Therefore, 
these results strongly suggest hat this enzyme behaves as 
a nucleosidetriphosphatase having more specificity for 
ATP. 
3.9. Divalent cation specifici~' 
Table 4B shows the effect of divalent cations on the 
Cl--stimulated ATPase and the following sequence of 
activation was found Mg2+>Mn2+>Ca2+.  However, 
Zn 2+ and Fe 2÷ were ineffective. 
3.10. Effects of  alkylating reagents 
In order to study the regulation exerted by SH groups 
on this enzyme activity, several alkylating compounds 
were employed. Two different compounds were used: 
NEM and p-CMB. It was found that pretreatment of these 
vesicles with NEM yielded a 35% inhibition of the C1-- 
stimulated ATPase and a 55% inhibition of the basal 
activity (data not shown). Using p-CMB, a dramatic inhibi- 
I0 
It is well known that V-ATPases can be activated by 
anions (specifically by chloride) but this property is also 
exhibited by other members of the halogen family. In this 
sense, several experiments were performed using different 
Na ÷ or K ÷ salts of different halogens (CI- ,  Br- ,  I - ,  F - ) .  
Table 3B shows the effect of these different salts on the 
Mg2+-ATPase. It can be seen that Br -  and I - ,  like 
chloride were good activators, but F -  was ineffective. 
From these data, a sequence order of effectiveness for 
halogen activation can be drawn as follows: C I ->  Br -> 
I ->> F -  regarding the metal ion employed. 
3.8. Nucleotide substrate specificity 
A Mg2-ATP  complex seems to be the substrate for 
ATPases and following this assumption, we explored the 
nucleotide specificity and the divalent requirements of this 
membrane bound ATPase. Table 4A shows the substrate 
specificity using different types of tri-, di- and 
monophoshonucleotides. Neither, the mononucleotides or
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Fig. 4. The p-CMB effect on the Mg2+-ATPase. Plasma membrane 
fractions were preincubated with p-CMB during 30 min at 4°C. After 
preincubation for 5 min at 37°C, the enzyme reaction was started upon 
the addition of ATP. The rest of the ATPase procedure was followed as 
described in Section 2. D, -KC1; III, +KC1 0.15 M. Each value is the 
mean + S.E. of three xperiments done in triplicate. 
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Fig. 5. Effect of duramycin on the Mg2+-ATPase activity. Duramycin at 
different concentrations was preincubated with plasma membranes (Pj) 
fraction (20-25 I~g) during 5 min at 37°C in the presence or absence of 1 
p,M valinomycin (Val). The ATPase reaction was started by the addition 
of ATP and the ezyme was measured as described in Section 2. Controls 
with 5 i~1 ethanol were done• [2, +Val +KC1; II, -Va l  +KC1; r,, 
+Val -KCI ;  - ,  -Va l  -KCI .  Each value is the mean+S.E, of three 
different experiments performed in triplicate. 
tion of the Cl--activated ATPase was observed, which is 
shown in Fig. 4. The p-CMB produced at 0.05 mM 31% 
inhibition, from 0.1 mM through 2.5 mM 68% inhibition, 
and at 5 mM complete inhibition. The basal activity was 
less sensitive at lower concentrations but at higher concen- 
trations of p-CMB both activities were completely inhib- 
ited. These data suggest that SH groups should be involved 
in the regulation of this ATPase. Additional experiments 
with other covalently modifying reagents were done, such 
as DCCD (500 p~M), which produced a complete inhibi- 
tion of C1--stimulated and basal Mg2+-ATPase (data not 
shown)• 
3.11. Relationship between a Cl-  conductor and the 
V-ATPase 
A H+-ATPase is associated with clathrin-coated vesi- 
cles, which is sensitive to duramycin. In addition; in these 
systems, a duramycin-sensitive chloride conductor has been 
postulated• It can be seen that duramycin in a dose depen- 
dent manner was able to inhibit more than 50% of the 
C1--stimulated ATPase. These results are shown in Fig. 5. 
This inhibition was smaller in the presence of 1 ~M 
valinomycin. It is important o emphasize that the basal 
activity in the presence or absence of valinomycin was 
completely insensitive to duramycin. These data support 
the hypothesis that a chloride transporter (conductor) is 
linked to this H÷-ATPase, which may be responsible for 
the C1- activation• All this evidence together supports the 
fact that there is a chloride conductor coupled to a V- 
ATPase in the plasma membrane vesicles isolated from 
airway smooth muscle• 
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Fig. 6. (A) The activation effect of FCCP on Mg2+-ATPase. Plasma membrane (Pi) (25-30 p,g protein) was incubated uring different imes in the 
presence of 10 p,M FCCP at 37°C. Controls with ethanol (5 ILl) were run simultaneously. II, + FCCP + KCL; [~, + FCCP -KC1; zx, -FCCP + KCI; 
A, - FCCP - KC1. (B) Dose-dependent activation of FCCP on chloride-stimulated enzyme. Samples were assayed at different FCCP concentration during 
1 min of incubation at 37°C. The ATPase activity was measured as described in Section 2. Controls with 5 ILl of ethanol were run simultaneously showing 
activity similar to control experiments. Each value is the mean of three different experiments done in triplicate. 
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3.12. Effects of  uncouplers on the V-ATPase 
Proton pumps can build up a pH gradient and a mem- 
brane potential (positive inside the vesicle) due to the 
active proton pumping activity. Protonophores (uncou- 
plers) are able to dissipate the pH gradient and in this way 
increase the ATPase activity of these H + pumps. The 
latter effect has been classically described for the F0-F 1- 
ATPases. V-ATPases have been associated with H + pumps 
in several membranes systems. In this sense, the effects of 
uncouplers on these enzyme activities were studied. Thus, 
FCCP was able to produce an activation of the C1-- 
activated ATPase as a function of time, which is shown in 
Fig. 6A. Similarly, FCCP was able to activate this ATPase 
activity in a dose-dependent manner, which is shown in 
Fig. 6B. It can be seen that FCCP increased the initial 
velocity of this ATPase, which suggests that this ATPase 
activity behaves like an uncoupled ATPase. These results 
were confirmed using another uncoupler as 1799, which 
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Fig. 7. Inmunoactivities of plasma membrane fraction PI with polyclonal 
antibody against A subunit of V-ATPase. The fraction Pj was run in 
SDS-10% polyacrylamide g lelectrophoresis as described in Section 2. 
(Lane A) Protein molecular weight standards containing: lysozyme (1) 
(14300); [3-1actoglobulin (2) (18400); carbonic anhydrase (3) (29000); 
ovalbumin (4) (43000); fumarase (5) (48 500); bovine serum albumin (6) 
(68 000); phosphorylase B (7) (97400). (Lane B) Polypeptide constant of 
Pi fraction stained with Coomasie brillant blue. (Lane C) Western 
blotting of plasma membrane fraction P~. This fraction (35 p.g protein) 
was transferred to nitrocellulose membranes and reacted with polyclonal 
antibody against A-subunit of V-ATPase at a dilution (1:100). Bound 
antibody was visualized by the immunoperoxidase coupled reaction en- 
hanced chemiluminescence detection system and exposed to Kodak-X- 
Omat film. 
showed a similar behavior as that found for FCCP (data 
not shown). All these data together indicate that there is a 
H + pump associated with a V-ATPase at plasma mem- 
brane vesicles isolated from airway smooth muscle. 
3.13. Western blotting for  detection of  A-subunit of  V- 
ATPase 
In order to have solid evidence on the existence of a 
V-ATPase associated with this plasma membrane fraction, 
a Western blotting protocol was performed in these plasma 
membrane samples using a polyclonal antibody against he 
subunit A (72 kDa) of the purified chromaffin granule 
V-ATPase. After, the immunoblotting procedure was per- 
formed, an immunoreactive band around 72 kDa was 
found using the experimental conditions. Several experi- 
mental conditions as membrane protein, antibodies dilution 
and exposition times were assayed to guarantee a clear 
band on the X-rays film, which is shown in Fig. 7 (Lane 
C). Additionally, molecular weight protein standards were 
run and the relative mobility of these markers is shown in 
Fig. 7 (Lane A). The polypeptide content was visualized 
using Coomassie brilliant blue stain as shown in Fig. 7 
(Lane B). 
4. Discussion 
The existence of highly active Mg 2 +-ATPases in plasma 
membrane fractions isolated from smooth muscles seems 
to be an original and important experimental finding 
[18,26]. Trying to understand the nature of this Mg 2+- 
ATPase, we decided to characterize this enzyme activity 
and to correlate it with the ion transport across airway 
smooth muscle plasma membranes. Transmembrane move- 
ments of ions may have an important impact on airway 
smooth muscle tone and contractibility by influencing a 
variety of cellular processes uch as intracellular ion con- 
centrations, membrane voltage and intracellular pH [27]. 
The presence of a V-ATPase associated to plasma mem- 
brane fractions isolated from the airway (tracheal) smooth 
muscle should be clearly demonstrated. In this sense, we 
decided to evaluate the presence of several classic markers 
of plasma membranes, which were determined. A good 
correlation was found between the subcellular distribution 
and the enrichment of plasma membrane markers such as 
5'-nucleotidase, GMP-PNP-stimulated adenylyl cyclase, 
muscarinic receptor activity with the V-ATPase here stud- 
ied. This evidence strongly supports the origin of these 
vesicles (Pl fraction), which derivated from plasma mem- 
brane structures. So far, we know this is the first report on 
the presence of a V-ATPase in plasma membrane struc- 
tures derived from non H +-secreting tissues such as smooth 
muscle cells. 
Several P- or F-ATPases specific inhibitors were used 
to confirm that such plasma membrane-bound ATPase are 
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indeed a V-ATPase. Thus; ouabain (a Na+,K--,Mg 2+- 
ATPase inhibitor) [28]; rutamycin (oligomycin C, a F0-F 1- 
ATPase inhibitor) [29] and vanadate (a general inhibitor 
for P-ATPases) [30] were unable to inhibit this C1--stimu- 
lated ATPase. These results have been described for most 
V-ATPases systems [31,32]. 
An important piece of evidence that allow us to identify 
this ATPase as V-ATPase was the dramatic inhibitory 
effect showed by low concentrations of bafilomycin A l on 
the chloride-stimulated ATPase. The V-ATPase proton 
pumps are inhibited (non-specifically) by dicyclohexyl- 
carbodiimide and sulfhydryl agents but recently a group of 
macrolide antibiotics, the bafilomycins, has been identified 
as specific, potent inhibitors of these V-ATPases [33,34]. 
The prototype bafilomycin A 1 is a specific inhibitor of the 
V-ATPases, in the nanomolar ange, and a 10000-fold 
increase in concentration is required before inhibition of 
other ion translocating ATPase is observed. Moreover, the 
bafilomycin-binding site seems to be located in the V 0 
sector of the V-ATPase [35]. 
These V-ATPases have been described in several organ- 
isms and mammalian tissues, specifically associated with 
the secretory vesicles [14-16], lysosomes [10], their asso- 
ciation with plasma membranes has been shown for sev- 
eral H÷-secreting cells as kidney cells [4,36,37]. This 
enzyme activity must be an integral part of the membrane 
structure [7,38] and the oligomeric catalytic sector of V- 
ATPase is composed of several subunits called A, B, C, D 
and E [7,38-40], that seem to be held together through 
hydrophobic interactions, which may be weaken through 
time at low temperature. A classic cold inactivation in the 
presence of ATP was performed for this ATPase and it 
was found that a significant inactivation of the V-ATPase 
occurred at 4°C in comparison to the enzyme activity 
incubated with ATP and Mg 2-- at 25°C. This last property 
has been described for some of these V-ATPases, which is 
the case for V-ATPase present in rat liver lysosomes, 
where the soluble sector of this V-ATPase became unsta- 
ble at low temperature due to the release of five subunits 
of the enzyme complex [41,42]. Another possible explana- 
tion for the cold inactivation may be due to the proteolytic 
activity, which can destroy some essential components 
[ 10]. A relevant aspect of the regulation of this V-ATPase 
is associated with the pH activity profile. Thus, the pH 
profile showed a very sharp optimal pH around 7.0, which 
has been described for most V-ATPases [4,40,43]. 
The function of SH groups at the catalytic activity of 
this V-ATPase was investigated by using NEM and p-CMB 
as alkylating agents. It was found that p-CMB was more 
potent han NEM inhibiting the chloride-stimulated and the 
basal activity suggesting that SH groups may be involved 
in the catalytic site of these ATPases. Our data are in good 
agreement with previous studies showing the inhibitory 
effect of alkylating reagents in several V-ATPases systems 
[44]. 
The anion stimulation of V-ATPase has been studied in 
many biological systems. The anion sensitivity of a V- 
ATPase has been demonstrated for the first time by Uchida 
et al. [45] in plant V-ATPase and by Moriyama nd Nelson 
[46] in animal V-ATPase. Thus, several V-ATPases showed 
great specificity to chloride ions [6,40]. In our case the 
following sequence of activation was found (C I -> NO 3 
> gluconate > SO42-), which has been described for other 
V-ATPases [47,48]. This chloride activation belongs to the 
halogen family being C I -> Br -> I -  the best activators 
and F -  was ineffective, which also has been described in 
some V-ATPases systems [32,49,50]. 
This V-ATPase is a powerful nucleosidetriphosphatase 
exhibiting a poor specificity for nucleosidetriphosphates 
being unable to hydrolyze di- or mononucleotides. Similar 
results have been shown by V-ATPases from other biologi- 
cal systems [4,13,43,51,52]. However, a high UTPase ac- 
tivity was found being only 20% sensitive to bafilomycin 
(unpublished results). These data suggested that the real 
substrate of these V-ATPases is a Mg 2+ ATP complex. In 
our system, it was found that Mg ~+ was the best divalent 
cation, which can be replace by Mn 2÷ [17,51,53]. How- 
ever; Zn 2+ and Fe 2÷ were poor divalent cations for this 
V- ATPase. The lack of effect of Fe z÷ seems to be 
different of the clathrin-coated vesicles [50] and lysosomal 
[54] V-ATPases. 
This chloride requirement can be explained through two 
mechanisms: (1) chloride may act at the catalytic site 
inducing activation of the enzyme or (2) chloride ions may 
dissipate the membrane potential created by the H+-pump 
activity of this V-ATPase. This latter hypothesis has been 
postulated in some systems, where, a V-ATPase seems to 
be coupled to a chloride conductor [31,32]. In addition, our 
results are similar on the chloride activation described for 
the clathrin-coated vesicles and endocytic vesicles [50]. In 
this sense; duramycin, an antibiotic polypeptide isolated 
from Streptomyces c innamoneus,  is a specific inhibitor of 
a chloride conductor coupled to the V-ATPase of ctathrin- 
coated vesicles from bovine brain [55]. This antibiotic was 
able to inhibit this chloride-stimulated ATPase present in 
plasma membrane vesicles from airway smooth muscle. 
Thus, duramycin inhibition can be explained by a direct 
inhibition of the H ÷ pump or the chloride conductor or 
both. Some evidences has been reported that duramycin 
may accomplish its effects through specific lipid- 
duramycin interactions instead of protein-duramycin 
lipid-duramycin [56,57]. Thus, the presence of phos- 
phatidylethanolamine (PE) in the membranes allows the 
formation of duramycin-PE complex, which in some man- 
ner can affect the function of the V-ATPase or the chloride 
transporter. 
V-ATPases have been demonstrated to be associated to 
H ÷ pumps activities. In this sense, it is known that AT- 
Pases associated to H ÷ pumps can be stimulated in the 
presence of conductive protonophores, which dissipate the 
proton gradients [7,58-60]. Thus, the effect of some un- 
couplers such as FCCP and 1799 was studied on this 
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V-ATPase.  In the sense, ATPase activity should increase 
when protonophores are used to dissipate pH gradients 
created by the active H + pumps. Our results support the 
idea that proton gradients and membrane potential created 
by the active accumulation of  H ÷ inside these vesicles can 
inhibit the hydrolytic activity of this V-ATPase.  Both 
uncouplers induced a signif icant stimulation of  this V- 
ATPase here described in a function of t ime and a dose-de- 
pendent manner. These data conf irm the existence of  a H ÷ 
pump energized by a V-ATPase,  which is associated to 
these plasma membrane vesicles. It is important o empha- 
size that the basal activity was not stimulated by uncou- 
plers indicating that the chloride-stimulated activity was 
the only one sensitive to protonophores. 
Altogether, the findings here described provide strong 
evidence about an original description a vacuolar type 
proton pump (V-ATPase)  associated to the airway smooth 
muscle plasma membrane fractions. 
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